We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Yourgene Health Plc | LSE:YGEN | London | Ordinary Share | GB00BN31ZD89 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.515 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2021 to Apr 2024
By Adria Calatayud
Yourgene Health PLC said Thursday that it has been awarded a contract to provide laboratory capacity to support the U.K. National Health Service's Test and Trace program for Covid-19 testing.
The U.K. molecular-diagnostics specialist said there is no committed spend under the deal and the actual value will depend on services purchased.
Yourgene said this is the first contract it has received as part of Public Health England's National Microbiology Framework, which allows public-health authorities to issue call-off contracts to procure goods and testing services.
Shares at 1113 GMT were up 4.1% at 15.10 pence.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
August 19, 2021 07:33 ET (11:33 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Yourgene Health Chart |
1 Month Yourgene Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
